KALOBIOS PHARMACEUTICALS INC's ticker is KBIO and the CUSIP is 48344T100. A total of 38 filers reported holding KALOBIOS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opus Point Partners Management, LLC | 746,467 | $358,000 | 0.28% |
| HARBOURVEST PARTNERS LLC | 57,604 | $28,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 4,327,600 | $2,077,000 | 0.00% |
| Renaissance Technologies | 564,673 | $271,000 | 0.00% |
| VALLEY WEALTH MANAGERS, INC. | 15,861 | $8,000 | 0.00% |
| CITIGROUP INC | 2,745 | $1,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 14,456 | $7,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 53,635 | $25,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 86,700 | $42,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,055 | $1,000 | 0.00% |